<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>26 patients with a <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> of at least 2 cm length (medium 4.9 cm) were treated with a combination of repeated <z:chebi fb="17" ids="49474,49475">argon</z:chebi>-plasma-coagulation (APC) and a long-term acid suppression using <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> controlled by a 2 h pH monitoring </plain></SENT>
<SENT sid="1" pm="."><plain>Eleven out of 26 patients (42%) showed endoscopically and histologically a complete eradication of the metaplastic cylindric epithelium (intention--to treat analysis) </plain></SENT>
<SENT sid="2" pm="."><plain>Nine patients (35%) had an endoscopic complete remission but remnants of the cylindric epithelium were found at the histologic examination </plain></SENT>
<SENT sid="3" pm="."><plain>On an average one APC-session was necessary for 1 cm of initial length of the <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>No serious complications were seen </plain></SENT>
<SENT sid="5" pm="."><plain>It remains unclear if this therapy can reduce the long-term risks for <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>